GSA Capital Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221K | Sell |
2,510
-341
| -12% | -$30K | 0.02% | 1458 |
|
|
2025
Q1 | $260K | Sell |
2,851
-231
| -7% | -$21.1K | 0.02% | 1248 |
|
|
2024
Q4 | $266K | Buy |
+3,082
| New | +$266K | 0.02% | 1267 |
|
|
2024
Q3 | – | Sell |
-13,316
| Closed | -$1.22M | – | 1925 |
|
|
2024
Q2 | $1.22M | Sell |
13,316
-5,293
| -28% | -$484K | 0.09% | 378 |
|
|
2024
Q1 | $1.69M | Buy |
18,609
+8,744
| +89% | +$793K | 0.13% | 173 |
|
|
2023
Q4 | $803K | Sell |
9,865
-3,345
| -25% | -$272K | 0.07% | 508 |
|
|
2023
Q3 | $1.06M | Buy |
13,210
+1,480
| +13% | +$118K | 0.09% | 365 |
|
|
2023
Q2 | $924K | Buy |
11,730
+2,886
| +33% | +$227K | 0.09% | 358 |
|
|
2023
Q1 | $687K | Buy |
+8,844
| New | +$687K | 0.07% | 518 |
|